WASHINGTON — It seemed like the debate over President Biden’s new high-stakes science agency, ARPA-H, was over.
Congress set aside $1 billion in funding. Cities began to lobby to host the new research office’s headquarters. And health secretary Xavier Becerra settled the lone point of controversy: The new agency, he declared in March, will exist not independently, but as a branch of the National Institutes of Health.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
